Personalized medicine for brain health:
From treating the illness to treating the individual
Genomind is a personalized medicine company bringing innovation to mental healthcare through genetic testing. Genomind’s expert staff is comprised of pioneering researchers and thought leaders in psychiatry and neurology who specialize in pharmacogenetic laboratory testing for psychiatry. Genomind is committed to partnering with clinicians to improve their patients’ lives.
The Genecept Assay® is a genetic test designed to help clinicians optimize treatment decisions for their patients with mental illness. It identifies patient-specific genetic markers that indicate which treatments are likely to work as intended, have no effect, or cause adverse effects. It is an easily administered cheek swab test that analyzes key genes, selected based on hundreds of studies showing that variations in these genes can inform treatment decisions.
The Assay is used to guide treatment for a range of psychiatric conditions, including:
- obsessive-compulsive disorder (OCD)
- attention deficit hyperactivity disorder (ADHD)
- bipolar disorder
- post traumatic stress disorder (PTSD)
- chronic pain
- substance abuse
The Assay has been shown in peer reviewed published studies to improve patient outcomes and reduce overall medical costs. Each Assay provides clinicians with an easy to read patient report and a complimentary psychopharmacogenomic consultation.